More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...

Dr Peter Marks is resigning as director of the FDA's Center for Biologics Evaluation and Research by April 5 due to objections to RFK Jr.

Against the backdrop of a rapidly expanding measles outbreak, what we need right now is urgent assistance from the federal ...

“What’s happening … is a reflection of the sprawling bureaucracy that’s actually making America sick and costing hundreds of ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...

Continuing to ask questions on an issue that has been answered multiple times, by multiple people, introduces doubt and anxiety. Our children deserve better.

Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.

Dr Sara Brenner, the FDA's principal deputy commissioner, has paused the approval process for Novavax's Covid-19 vaccine by ...

In different parts of the UK, the groups who qualify for a spring booster are the same but the dates of the campaign are slightly different: The NHS uses vaccines from two companies across the UK ...